{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:12:17Z","timestamp":1782958337643,"version":"3.54.5"},"reference-count":37,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cell Biology International"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label\/><jats:p>Tripartite motif\u2010containing 22 (TRIM22) is reported to participate in numerous cellular activities. Recent studies confirm that TRIM22 is a target gene for P53, and inhibits clonogenic growth of leukemic U\u2010937 cells. The current study aims to discover the effect of TRIM22 in progression of human chronic myeloid leukemia (CML) and explore the related mechanism. TRIM22 was knocked down by siRNA transfection in CML cell K562. We observed that TRIM22 knockdown decreased proliferation and invasion in K562 cells. TRIM22 knockdown significantly induced cell cycle arrest by regulating the level of CDK4, Cyclin D1, P70S6K, and P53 in K562 cell. Moreover, loss of TRIM22 also promoted apoptosis through modulation of Bcl\u20102, Bax and active Caspase 3 in K562 cell. Furthermore, we demonstrated that TRIM22 knockdown inhibited the activation of PI3K\/Akt\/mTOR pathway by decreasing the level of the phosphorylated form p\u2010Akt and p\u2010mTOR in K562 cell. In conclusion, loss of TRIM22 suppresses the progression and invasion of CML through regulation of PI3K\/Akt\/mTOR pathway, suggesting that TRIM22 might be as a potential target for the treatment strategy of CML.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cbin.10989","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T12:40:28Z","timestamp":1526388028000},"page":"1192-1199","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K\/Akt\/mTOR signaling pathway"],"prefix":"10.1002","volume":"42","author":[{"given":"Liyin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology Yunnan Research Center of Hematology, the First Affiliated Hospital of Kunming Medical University Kunming P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Yuhuangding Hospital of Qingdao University Yantai P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Yunnan Institute of Experimental Diagnosis, the First Affiliated Hospital of Kunming Medical University Yunnan Key Laboratory of Laboratory Medicine No. 295, Xichang Road Kunming City Yunnan Province P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery the First Affiliated Hospital of Kunming Medical University Kunming P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urinary Surgery the First People's Hospital of Kunming City Kunming P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixia","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Yuhuangding Hospital of Qingdao University Yantai P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.309"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000007"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.07.025"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403898"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105200"},{"key":"e_1_2_8_7_1","first-page":"526","article-title":"Emodin exerts an antiapoptotic effect on human chronic myelocytic leukemia K562 cell lines by targeting the PTEN\/PI3K\u2010AKT signaling pathway and deleting BCR\u2010ABL","volume":"16","author":"Chun\u2010Guang W","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3441"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02548-12"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01362"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2003.07.007"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039824"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc776"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10155"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530130416"},{"key":"e_1_2_8_16_1","first-page":"955","article-title":"MicroRNA\u2010130a regulates cell malignancy by targeting RECK in chronic myeloid leukemia","volume":"8","author":"Li Q","year":"2016","journal-title":"Am J Transl Res"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312742"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18911"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.01.004"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2011.06.017"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1248"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207524"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.12.012"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:APPT.0000045801.15585.dd"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008672"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147185"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2015.1026321"},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1182\/blood.V120.21.3736.3736","article-title":"Commitment of CML cells to apoptotic cell death depends on the length of exposure to das and the level of STAT5 activity","volume":"120","author":"Schafranek L","year":"2012","journal-title":"Blood"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01810-10"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<556::AID-PATH294>3.0.CO;2-Y"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2869"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.10.110"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-0563"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167052"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.131"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142596"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-169X.2010.01209.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21564"}],"container-title":["Cell Biology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcbin.10989","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbin.10989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T10:38:43Z","timestamp":1695033523000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cbin.10989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1002\/cbin.10989"],"URL":"https:\/\/doi.org\/10.1002\/cbin.10989","archive":["Portico"],"relation":{},"ISSN":["1065-6995","1095-8355"],"issn-type":[{"value":"1065-6995","type":"print"},{"value":"1095-8355","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"2018-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}